Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

Carcinoembryonic antigen (CEA) affects tumorigenesis by enhancing tumor cell survival and by inducing tumor angiogenesis. This study aimed to evaluate baseline CEA serum levels to predict bevacizumab-based therapy effect and survival in patients with metastatic colorectal cancer (mCRC). Two hundred...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Autores principales: Prager, Gerald W, Braemswig, Kira H, Martel, Alexandra, Unseld, Matthias, Heinze, Georg, Brodowicz, Thomas, Scheithauer, Werner, Kornek, Gabriela, Zielinski, Christoph C
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4317865/
https://ncbi.nlm.nih.gov/pubmed/24850362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12451
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares